Compare Novartis with MANAKSIA. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs MANAKSIA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS MANAKSIA. NOVARTIS/
MANAKSIA.
 
P/E (TTM) x 86.5 4.2 2,063.8% View Chart
P/BV x 2.7 0.4 641.8% View Chart
Dividend Yield % 1.3 4.9 26.2%  

Financials

 NOVARTIS   MANAKSIA.
EQUITY SHARE DATA
    NOVARTIS
Mar-21
MANAKSIA.
Mar-21
NOVARTIS/
MANAKSIA.
5-Yr Chart
Click to enlarge
High Rs77065 1,188.3%   
Low Rs50128 1,818.5%   
Sales per share (Unadj.) Rs154.5131.4 117.5%  
Earnings per share (Unadj.) Rs8.59.9 85.9%  
Cash flow per share (Unadj.) Rs13.414.7 91.1%  
Dividends per share (Unadj.) Rs10.003.00 333.3%  
Avg Dividend yield %1.66.5 24.2%  
Book value per share (Unadj.) Rs289.2145.9 198.2%  
Shares outstanding (eoy) m24.6965.53 37.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.4 1,170.8%   
Avg P/E ratio x75.14.7 1,603.1%  
P/CF ratio (eoy) x47.53.1 1,510.7%  
Price / Book Value ratio x2.20.3 694.2%  
Dividend payout %118.130.4 388.3%   
Avg Mkt Cap Rs m15,6913,026 518.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,085426 255.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8148,610 44.3%  
Other income Rs m332326 101.7%   
Total revenues Rs m4,1468,937 46.4%   
Gross profit Rs m2671,010 26.4%  
Depreciation Rs m122317 38.4%   
Interest Rs m7759 130.4%   
Profit before tax Rs m400961 41.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m191315 60.8%   
Profit after tax Rs m209646 32.3%  
Gross profit margin %7.011.7 59.6%  
Effective tax rate %47.832.7 146.0%   
Net profit margin %5.57.5 73.0%  
BALANCE SHEET DATA
Current assets Rs m9,2249,451 97.6%   
Current liabilities Rs m3,5731,484 240.8%   
Net working cap to sales %148.292.5 160.2%  
Current ratio x2.66.4 40.5%  
Inventory Days Days176267 66.0%  
Debtors Days Days37248 14.9%  
Net fixed assets Rs m2,4802,239 110.8%   
Share capital Rs m123131 94.1%   
"Free" reserves Rs m7,0189,430 74.4%   
Net worth Rs m7,1419,561 74.7%   
Long term debt Rs m01 0.0%   
Total assets Rs m11,70311,689 100.1%  
Interest coverage x6.217.3 35.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.30.7 44.2%   
Return on assets %2.46.0 40.5%  
Return on equity %2.96.8 43.3%  
Return on capital %6.710.7 62.7%  
Exports to sales %9.30-   
Imports to sales %00.9 0.0%   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNA81 0.0%   
Fx inflow Rs m35487 404.4%   
Fx outflow Rs m97481 1,204.7%   
Net fx Rs m-6217 -9,476.2%   
CASH FLOW
From Operations Rs m-6922,789 -24.8%  
From Investments Rs m952-3,024 -31.5%  
From Financial Activity Rs m-368328 -112.3%  
Net Cashflow Rs m-109-477 22.7%  

Share Holding

Indian Promoters % 0.0 74.9 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.3 300.0%  
FIIs % 0.0 0.3 11.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 25.1 117.0%  
Shareholders   45,141 26,089 173.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   CHEMO PHARMA  A.V.COTTEX  TEMBO GLOBAL  METROGLOBAL.  ADD-SHOP PROMOTIONS   



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

MANAKSIA. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 2, 2021 | Updated on Nov 2, 2021

Here's an analysis of the annual report of MANAKSIA. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of MANAKSIA.. Also includes updates on the valuation of MANAKSIA..

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Dec 3, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - GRANDEUR PRODUCTS COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS